1.
Ter Arkh
; 68(4): 9-11, 1996.
Article
in Russian
| MEDLINE
| ID: mdl-9324808
ABSTRACT
Hemosorption and plasmapheresis were used in 26 patients with episodes of atrial fibrillation and extrasystoles. A response lasting 4 +/- 0.9 months was registered in 80% of cases. Negative effects were absent.
Subject(s)
Atrial Fibrillation/therapy , Cardiac Complexes, Premature/therapy , Hemoperfusion , Plasmapheresis , Adult , Aged , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/blood , Cardiac Complexes, Premature/blood , Chronic Disease , Combined Modality Therapy , Female , Hemoperfusion/adverse effects , Hemoperfusion/instrumentation , Humans , Male , Middle Aged , Plasmapheresis/adverse effects , Plasmapheresis/instrumentation
2.
Ter Arkh
; 66(8): 35-6, 1994.
Article
in Russian
| MEDLINE
| ID: mdl-7985150
ABSTRACT
The authors present pilot experience in extracorporeal blood purification (hemosorption, plasmapheresis) aimed at correction of cardiac arrhythmia. Seven responders of 8 patients treated had less frequent episodes of cardiac fibrillation the severity of which decreased, they suffered no more from high-grade extrasystoles, were put on reduced doses of antiarrhythmic drugs. The response is attributed to improvement of blood rheology and elimination of arrhythmogenic substances.